The Company is a Korea-based company principally engaged in development and manufacture of vitro diagnostic medical device for immunological diagnosis. The Company's products include blood bank screening products and quick diagnostic products. And the Company also provides platform services. The Company was established on February 12, 2008. The Company share was listed on the Korea Securities Dealers Automated Quotation System ( KOSDAQ ) on February 23, 2017.
Headquarters
701, 99, Digital-Ro 9-Gi, Geumcheon-Gu
Seoul; Seoul;
Contact Details: Purchase the PCL Inc. report to view the information.
Website: http://www.pclchip.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service